Suppression of natural killer cell activity in patients with fracture/soft tissue injury

Archives of Surgery

Volumn 132, Issue 12, 1997, Pages 1326-1330

  Hauser, Carl J ^a   Joshi, Pratibha ^b   Jones, Quintus ^b   Zhou, Xinchun ^b   Livingston, David H ^a   Lavery, Robert F ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; NEUTRALIZING ANTIBODY; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CYTOLYSIS; FRACTURE; FRACTURE FIXATION; HUMAN; HUMAN CELL; MONONUCLEAR CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; SOFT TISSUE INJURY;

EID: 0031452327     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.1997.01430360072013     Document Type: Article

References (25)

1. Trinchieri G. Biology of natural killer cells. Adv Immunol. 1989;47:187-376.
2. Trinchieri G. Interleukin-12: a pro-inflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol. 1995;13:251-276.
3. Rosati E, Scaringi L, Cornacchione P, et al. Cytokine response to inactivated Candida albicans in mice. Cell Immunol. 1995;162:256-264.
4. Cowdery JC, Chase JH, Yi AK, Kreig AM. Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccarides. J Immunol. 1996;156:4570-4575.
5. Mond JJ, Lees A, Snapper CM. T cell - independent antigens type 2. Annu Rev Immunol. 1995;13:655-692.
6. Kos FJ, Engelman EG. Role of natural killer cells in the generation of influenza virus - specific cytotoxic T-cells. Cell Immunol. 1996;173:1-6.
7. Faist E, Mewes A, Strasser T, et al. Alteration of monocyte function after major injury. Arch Surg. 1988;123:287-292.
8. Ayala A, Ertel W, Chaudry IH. Trauma induced suppression of antigen presentation and expression of major histocompatibility class II antigen complex in leukocytes. Shock. 1996;5:79-90.
9. Morrison G, Cunningham-Rundles S, Clowes GH, Stahl WM. Augmentation of NK cell activity by a circulating peptide isolated from the plasma of trauma patients. Ann Surg. 1986;203:21-24.
10. Prochazka M, Vyhnanek F, Jira M, Strejcek J. Effect of interleukin-2 on peripheral blood mononuclear cells in severely injured patients. Acta Chir Scand. 1987; 153:401-404.
11. Joshi P, Hauser CJ, Zhou X. NK cell activity is suppressed by serum from trauma patients. J Allergy Clin Immunol. 1997;99:LB86.
12. Barbul A, Fishel RS, Shimazu S, et al. Inhibition of host immunity by fluid and mononuclear cells from healing wounds. Surgery. 1984;96:315-319.
13. Lazarou SA, Barbul A, Wasserkrug HL, Efron G. The wound is a possible source of posttraumatic immunosuppression. Arch Surg. 1989;124:1429-1431.
14. Seibel R, LaDuca J, Hasset JM, et al. Blunt multiple trauma (ISS 36), femur traction, and the pulmonary failure - septic state. Ann Surg. 1985;202:283-295.
15. Wichman MW, Zellweger R, DeMaso CM, Ayala A, Williams C, Chaudry IH. Immune function is more compromised after closed bone fracture and hemorrhagic shock than hemorrhage alone. Arch Surg. 1996;131:995-1000.
16. Napolitano LM, Koruda MJ, Meyer AA, Baker CC. The impact of femur fracture with associated soft tissue injury on immune function and intestinal permeability. Shock. 1996;5:202-207.
17. Hauser CJ, Zhou X, Joshi P, et al. The immune micro-environment of human fracture/soft tissue hematomas and its relationship to systemic immunity. J Trauma. 1997;42:895-904.
18. Lane DR, Joshi P, Grogan JB, Nie CH, Scott-Connor CEH. Suppression of natural killer cell activity in biliary obstruction. Am Surg. 1996;62:259-262.
19. Hauser CJ, Joshi P, Zhou X, et al. Production of interleukin-10 in human fracture/ soft-tissue hematomas. Shock. 1996;6:3-6.
20. Hansch GM, Seitz M, Martinotti G, et al. Macrophages release arachidonic acid, prostaglandin E2 and thromboxane in response to late complement components. J Immunol. 1984;133:2145-2150.
21. Hansson M, Asea A, Ersson U, et al. Induction of apoptosis in NK cells by monocyte-derived reactive oxygen metabolites. J Immunol. 1996;156:42-47.
22. Moore KW, O'Garra A, de Waal Malefyt R, et al. Interleukin-10. Annu Rev Immunol. 1993;11:165-190.
23. Carson WE, Lindemann MJ, Baiocchi R, et al. The functional characterization of interleukin-10 receptor expression on human natural killer cells. Blood. 1995; 85:3577-3585.
24. Zheng LM, Ojcius DM, Garaud F, et al. Interleukin-10 inhibits tumor metastasis through an NK-cell dependent mechanism. J Exp Med. 1996;184:579-584.
25. Bluman EM, Bartynski KJ, Avalos BR, Caligiuri MA. Human natural killer cells produce abundant macrophage inflammatory protein 1-alpha in response to monocyte-derived cytokines. J Clin Invest. 1996;97:2722-2727.